Form 4 for MANE Veradermics, Inc
Accepted 2026-02-05 00:00:00 ET · period of report 2026-02-03 · accession 0001628280-26-005898 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-05 | 2026-02-05 | MANE | Durso Timothy August | Chief Technical Off | C - Cnv Deriv | — | +1,473 | 118.2K | +1% | — |
| D | 2026-02-05 | 2026-02-05 | MANE | Durso Timothy August | Chief Technical Off | C - Cnv Deriv | — | -1,473 | 0 | -100% | — |
| D | 2026-02-05 | 2026-02-03 | MANE | Durso Timothy August | Chief Technical Off | A - Grant | $0.00 | +213.4K | 213.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-05 | C | A | 1,473 | — | 118,190 | D | — | — | (F1) On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (the "Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date. |
| 2 | Derivative | Series A Convertible Preferred Stock | 2026-02-05 | C | D | 1,473 | — | 0 | D | — · — to — | 1,473 Common Stock | (F1) On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (the "Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-02-03 | A | A | 213,352 | $0.00 | 213,352 | D | $17.00 · — to 2036-02-03 | 213,352 Common Stock | (F3) The option vests as to 25% of the underlying shares of Common Stock on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service. |